Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1055-1065
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1055
Table 2 Comparison of the clinical data in the transfer and non-transfer groups
Considerations
Transfer group (n = 52)
Non-transfer group (n = 190)
t/z/χ2
P value
SII385.21 ± 78.63264.29 ± 64.43-10.19< 0.01
CAR1.02 ± 0.400.79 ± 0.38-3.88< 0.01
RDW (FL)17.64 ± 1.9816.28 ± 1.26-4.72< 0.01
Total bilirubin (µmol/L)13.45 ± 2.5113.75 ± 3.280.710.48
Albumin (g/L)42.08 ± 3.8142.22 ± 2.710.250.80
Blood platelet count (109/L)167.13 ± 65.02157.29 ± 40.59-1.040.30
WBC (109/L)7.48 ± 2.587.52 ± 3.120.080.93
ALT (U/L)47.88 ± 1.8448.50 ± 1.592.400.017
AST (U/L)47.29 ± 1.2547.14 ± 1.76-0.610.54
Surgical procedures0.010.94
Laparoscopy32 (61.50)118 (62.10)
Open the abdomen20 (38.50)72 (37.90)0.010.93
Vascular invasion3.260.07
Yes24 (46.20)62 (32.60)
No28 (53.80)128 (67.40)1.580.21
Tumor site1.010.32
Left30 (57.70)124 (65.30)
Right22 (42.30)66 (34.70)
Pathological type1.050.31
Adenocarcinoma48 (92.30)182 (95.80)
Other4 (7.70)8 (4.20)
Postoperative chemotherapy3.260.07
Yes24 (46.20)62 (32.60)
No28 (53.80)128 (67.40)
Preoperative CEA (μg/L)9.59< 0.01
< 5 21 (40.40)122 (64.20)
≥ 531 (59.60)68 (35.80)
Lymphatic node transfer4.900.03
Yes28 (53.80)70 (36.80)
No24 (46.20)120 (63.20)